Lv51
810 积分 2026-01-06 加入
Efficacy and safety of immunotherapy in advanced pulmonary large-cell neuroendocrine carcinoma: A systematic review and meta-analysis
28天前
已完结
Management of Pulmonary Large-Cell Neuroendocrine Carcinoma (LCNEC): An Updated Review
28天前
已完结
Management, biomarkers and prognosis in people developing endocrinopathies associated with immune checkpoint inhibitors
1个月前
已完结
96 weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection
2个月前
已完结
Interstitial lung disease biomarkers: a systematic review and meta-analysis
3个月前
已完结
Pooled analysis of trastuzumab deruxtecan retreatment after recovery from grade 1 interstitial lung disease/pneumonitis
3个月前
已完结
Drug-induced interstitial lung disease: a narrative review of a clinical conundrum
3个月前
已完结
Trilaciclib: First Approval
4个月前
已完结
Discovery of Potent and Selective CDK4/6 Inhibitors for the Treatment of Chemotherapy-Induced Myelosuppression
4个月前
已完结
Trilaciclib plus chemotherapy versus chemotherapy alone in patients with metastatic triple-negative breast cancer: a multicentre, randomised, open-label, phase 2 trial
4个月前
已完结
皖公网安备34019202002308
